NGN Capital
Overview
Ngn capital corp Ngn capital is a venture capital firm dedicated to healthcare investing, focusing on ventures with the potential to achieve above average private equity returns with an emphasis on later stage investments. The funds have flexibility to invest in a broad cross section of healthcare and biotechnology segments including drug products, medical devices and other healthcare segments like services. The funds are diversified by stage, from later stage to selected early stage opportunities, as well as by geography by investing predominantly in the US and in Europe.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| OptiScan Biomedical Corporation | Oct 2005 | Series B | Lead |
| Cerapedics | Dec 2012 | Series C | Co-investor |
| Vivaldi Biosciences, Inc. | Jan 2009 | Series A | Lead |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is NGN Capital based?
NGN Capital is headquartered in Stamford, Connecticut, United States.
When was NGN Capital founded?
NGN Capital was founded in 2003.
How many portfolio companies does NGN Capital have?
NGN Capital has 4 portfolio companies in Caplight's dataset.
What are some companies in NGN Capital's portfolio?
Portfolio companies visible on Caplight include OptiScan Biomedical Corporation, Cerapedics, Vivaldi Biosciences, Inc..
What was NGN Capital's most recent investment shown here?
NGN Capital's most recent investment in this portfolio sample was in Cerapedics in 2012.
What sectors does NGN Capital focus on?
NGN Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does NGN Capital focus on?
NGN Capital typically invests at the Mid stage.
What is NGN Capital's AUM?
NGN Capital's assets under management are estimated between $100.0M and $250.0M.